Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Dabrafenib btd date 2023?What are the most memorable drug brands in oral factor b inhibitors? in united statesPatent expiration eu dabrafenib?Can grapefruit consumption affect lipitor's efficacy?Combivent inhaler hfc 152a patents?
See the DrugPatentWatch profile for tigecycline
Tigecycline (Tygacil) is administered intravenously for complicated skin and skin structure infections (cSSSI), complicated intra-abdominal infections (cIAI), and hospital-acquired/ventilator-associated bacterial pneumonia (HABP/VABP). The recommended dose is 100 mg loading dose followed by 50 mg every 12 hours. Treatment duration is 5-14 days depending on infection type.[1][2]
No adjustments needed for renal or hepatic impairment, but use caution in severe liver disease (Child-Pugh C); reduce maintenance to 25 mg every 12 hours after 100 mg load. Tigecycline is not approved for pediatric use under 18 or pregnant patients.[1][2]
Administer as soon as possible, then resume schedule. Do not double dose.[1]
Infuse over 30-60 minutes. Compatible with normal saline or dextrose. Avoid rapid infusion to minimize nausea.[2]
FDA-approved 2013 update raised pneumonia dose to 100 mg every 12 hours due to higher MICs for pathogens like Acinetobacter, improving outcomes in trials.[1][3] [1]: Tygacil Prescribing Information (Pfizer) [2]: Drugs.com - Tigecycline Dosage [3]: FDA Label Update Summary
Other Questions About Tigecycline :